You searched for "Genetics"

785 results found

Quality matters in the management of serious eye disorders

The author discusses the first quality standard for serious eye disorders from NICE and takes a look at new care models for enhanced service delivery. Patient backlogs pose risks to patient safety, with research showing that people are losing sight...

Ground-breaking achievements in blindness prevention

One small UK based charity is enabling pioneering research to prevent blindness in low and lower middle income countries. The British Council for Prevention of Blindness (BCPB), established in 1976, funds innovative research and training which seeds the development of...

Management of DMO and PDR in 2019

An evidence-based approach to the management of diabetic macular oedema (DMO) and proliferative diabetic retinopathy (PDR) in 2019 was outlined by Sobha Sivaprasad, UK, in presentations during the Diabetic Retina scientific session September 6 2019, at the 19th European Society...

Could Twitter boost the impact of ophthalmic journal articles?

*Equally contributing co-first authors. The authors investigate the link between ‘tweets’ and citations for 155 articles from five key ophthalmology journals. Social media’s impact on our lives has been significant, allowing easy discussion of topics worldwide. An increasing number of...

Virtual ophthalmic conferences: learnings from the Covid-19 pandemic

The Covid-19 pandemic was the catalyst for a number of paradigm shifts in numerous industries. The demand for proxies that follow social distancing measures created a hotbed for digital solutions and transitioned these to social convention. In the aftermath, the...

In conversation with Marc Labetoulle

Following the hugely successful 10th Tear Film & Ocular Surface Society (TFOS) 2024 Conference which took place in Venice, Italy between 30 October – 2 November, we managed to have a quick Q&A with presenting attendee, Marc Labetoulle. Delivering his...

Conference Preview: UKISCRS, UKISOP and YOP 2025

London’s calling, and we will be rejoining the United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS), the Young Ophthalmologists Programme (YOP), and United Kingdom & Ireland Society of Ophthalmic Practitioners (UKISOP) between 12–14 November. The former will...

World-first platform for transparent, fair and equitable use of AI in healthcare

Revolutionary AI platform for detecting diabetic eye disease proven safe for NHS. Researchers have developed the world’s first real-world head-to-head testing platform to determine whether commercial artificial intelligence (AI) algorithms are fit for NHS use to detect disease in a...

RNIB volunteers “honoured” to meet HM The King and HM The Queen

Two volunteers with sight loss visited Windsor earlier this month to meet Royalty and explain how volunteering can bring communities together. Jonathan Abro and Simon Holt, who both volunteer for RNIB (Royal National Institute of Blind People), were part of...

Scottish Government announces permanent free rail travel for companions of visually impaired people

Sight Scotland and Sight Scotland Veterans welcome the Scottish Government announcement today that free rail travel for companions of visually impaired people has been made a permanent policy across all ScotRail and Caledonian Sleeper services. Sight Scotland and Sight Scotland...

New GIRFT glaucoma guidance – opportunities for improvement through primary eyecare services

Primary eyecare organisations have welcomed the publication of NHS England's Getting It Right First Time (GIRFT) Best Practice Guidance for Glaucoma Services. If implemented by ICBs as intended, the new guidance should mark an important step forward in the delivery...

Ocular toxicity secondary to deferoxamine

Patients with myelodysplastic syndromes can develop transfusion-related iron overload as they become dependent on recurrent blood transfusions [1]. Iron chelation therapy is indicated for the treatment of iron overload and one established example of this is deferoxamine. However, deferoxamine ocular...